GUCY1A3 Gene Moyamoya type 6 with achalasia Genetic Test
At DNA Labs UAE, we offer the GUCY1A3 Gene Moyamoya type 6 with achalasia Genetic Test at a cost of AED 4400.0. This test is used to diagnose and detect genetic variants in the GUCY1A3 gene, which is associated with Moyamoya disease type 6 and achalasia.
Test Components
Price: AED 4400.0
Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery: 3 to 4 Weeks
Method: NGS Technology
Test Type: Vascular Diseases
Doctor: General Physician
Test Department: Genetics
Pre Test Information
Prior to the GUCY1A3 Gene Moyamoya type 6 with achalasia Genetic Test, it is important to provide the clinical history of the patient who is undergoing the test. Additionally, a genetic counseling session may be conducted to draw a pedigree chart of family members affected by GUCY1A3 Gene Moyamoya type 6 with achalasia NGS Genetic DNA Test gene GUCY1A3.
Test Details
The GUCY1A3 gene is associated with Moyamoya disease, specifically type 6. Moyamoya disease is a rare cerebrovascular disorder that affects the blood vessels in the brain, leading to progressive narrowing and eventual blockage. This can result in strokes, transient ischemic attacks (TIAs), and other neurological symptoms.
In addition to Moyamoya disease, the individual in question also has achalasia. Achalasia is a disorder that affects the esophagus and impairs its ability to move food into the stomach. This can cause difficulty swallowing, regurgitation, and chest pain.
The NGS genetic test, or Next-Generation Sequencing genetic test, is a type of genetic testing that allows for the simultaneous analysis of multiple genes. It is commonly used to identify mutations or variants in genes associated with specific diseases or conditions, such as Moyamoya disease.
In summary, the GUCY1A3 gene mutation is associated with Moyamoya disease type 6, and the individual in question also has achalasia. The NGS genetic test can be used to detect genetic variants in the GUCY1A3 gene and potentially provide insights into the underlying cause of these conditions.
| Test Name | GUCY1A3 Gene Moyamoya type 6 with achalasia Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Vascular Diseases |
| Doctor | General Physician |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for GUCY1A3 Gene Moyamoya type 6 with achalasia NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with GUCY1A3 Gene Moyamoya type 6 with achalasia NGS Genetic DNA Test gene GUCY1A3 |
| Test Details | The GUCY1A3 gene is associated with a condition called Moyamoya disease, specifically type 6. Moyamoya disease is a rare cerebrovascular disorder that affects the blood vessels in the brain, leading to progressive narrowing and eventual blockage. This can result in strokes, transient ischemic attacks (TIAs), and other neurological symptoms. Additionally, the individual mentioned in your query also has achalasia, which is a disorder that affects the esophagus and impairs its ability to move food into the stomach. This can cause difficulty swallowing, regurgitation, and chest pain. The NGS genetic test, or Next-Generation Sequencing genetic test, is a type of genetic testing that allows for the simultaneous analysis of multiple genes. It is commonly used to identify mutations or variants in genes associated with specific diseases or conditions, such as Moyamoya disease. In summary, the GUCY1A3 gene mutation is associated with Moyamoya disease type 6, and the individual in question also has achalasia. The NGS genetic test can be used to detect genetic variants in the GUCY1A3 gene and potentially provide insights into the underlying cause of these conditions. |
